Home/Filings/4/0001384101-25-000068
4//SEC Filing

Febbo Phillip G. 4

Accession 0001384101-25-000068

CIK 0001384101other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:00 PM ET

Size

5.1 KB

Accession

0001384101-25-000068

Insider Transaction Report

Form 4
Period: 2025-06-02
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Tax Payment

    Common Stock

    2025-06-02$26.74/sh2,955$79,017103,745 total
Footnotes (1)
  • [F1]The reporting person is reporting the withholding of 1,688 and 1,267 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,324 and 2,494 Restricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001649245

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:00 PM ET
Size
5.1 KB